Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Post by jros22on Jul 26, 2020 8:59am
247 Views
Post# 31320357

Quidel test problems

Quidel test problemshttps://www.bostonglobe.com/2020/07/22/nation/tale-two-tests-vermont-city-left-puzzled-by-positive-then-negative-covid-19-results/?outputType=amp&__twitter_impression=true

Has this been shared? There's no way Quidel has a product that's ready for widespread use. They rushed their product out and I see it backfiring on them soon. Their in-house validation used frozen samples. No third party validation or clinical trials. Now they claim 96.7% accuracy? It's crazy to claim that without a third party validation. I can see a lawsuit at some point. 

Although most of us here wanted Sona to have a product out in April as Jim implied in his interview, the Sona team has made all the right moves. Product development takes time. A couple months ago I was dreaming about the day this stock hits $10. Now we're at $14 and not even approved yet. Triple digits will easily be achievable here. David said we can produce 1 billion tests (no timeline on that). We have one shot to get the best product on the market and then mass produce the sh*t out of it. Imagine if we are invested in the gold standard of testing. A demand as big as it gets and a competition with an inferior product. This company is going to change a lot of lives! 
Bullboard Posts